Carbamazepine Gel Formulation as a Sustained Release Epilepsy Medication for Pediatric Use
This study aimed to develop a carbamazepine (CBZ) sustained release formulation suitable for pediatric use with a lower risk of precipitation. The CBZ was first prepared as sustained release microparticles, and then the microparticles were embedded in alginate beads, and finally, the beads were susp...
Main Authors: | Saeid Mezail Mawazi, Sinan Mohammed Abdullah Al-Mahmood, Bappaditya Chatterjee, Hazrina AB. Hadi, Abd Almonem Doolaanea |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/11/10/488 |
Similar Items
-
Interchangeability among carbamazepine formulations: the impact over epilepsy patients
by: Virgínia Paula Frade, et al.
Published: (2022-07-01) -
Study of efficacy of the combination of carbamazepine with nootropics on cognitive processes in epilepsy
by: Ivanov A.V., et al.
Published: (2013-03-01) -
Pragmatic study of efficiency of controlled-release carbamazepine (TEGRETOL CR 400) in the treatment of patients with partial seizures
by: Vojvodić Nikola M., et al.
Published: (2002-01-01) -
A quick review of carbamazepine pharmacokinetics in epilepsy from 1953 to 2012
by: Zahra Tolou-Ghamari, et al.
Published: (2013-01-01) -
Possible pathogenetic mechanisms of failure epilepsy treatment with carbamazepine
by: K. V. Krikova, et al.
Published: (2016-08-01)